Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+12.29%
+4.37%
+6.14%
+2.42%
+18.53%
EBS
Emergent Biosolution
$5.98
Chart
$6.3 (-5.08%)
$4.62 (+29.44%)
$5.85 (+2.22%)
$14.77 (-59.51%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+12.29%
+4.37%
+6.14%
+2.42%
+18.53%
EBS
Emergent Biosolution
Current Price
$5.98
Login to view Emergent Biosolution (EBS) recommendation from the last 90 days from financial news and social media.
Chart
$6.3 (-5.08%)
$4.62 (+29.44%)
$5.85 (+2.22%)
$14.77 (-59.51%)
EBS Latest Analysis
TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500. By Financial UpdateOn July 25 2025 Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) filed an 8-K in which it disclosed preliminary operating results for the second quarter of 2025. Net revenue from product sales for the quarter ended June 30 2025 was approximately $2.0 million compared to $2.2 million for the quarter ended June 30 2024. Net operating loss for the second quarter of 2025 was approximately $26.3 million compared to $78.8 mil
Tue Jul 29, 2025
Viking Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update. Conference call scheduled for Phase 3 VANQUISH Registration Trials Underway for VK2735 in ObesityPhase 2 VENTURE-Oral Dosing Trial Enrollment Completed. Top-Line Results Expected 2H25Continued Progress with Amylin Program. IND Planned 4Q25Strong Quarter-End Cash Position of ) a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders
Wed Jul 23, 2025
Kemin Launches RevoCURB™ an OMRI-Listed® Botanical-Oil-Based Soil Treatment for Soil Health. New alternative to soil fumigation controls plant-parasitic nematodes soilborne pathogens and pre-emergent weed seeds in all crop soils DES MOINES Iowa July 15 2025 /PRNewswire/ -- Kemin Industries a global ingredient manufacturer that strives to sustainably transform the quality of...
Tue Jul 15, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings